---
figid: PMC12108454__antioxidants-14-00605-g003
figtitle: OS leads to the overproduction of ROS
organisms:
- NA
organisms_ner:
- Homo sapiens
- Danio rerio
pmcid: PMC12108454
filename: antioxidants-14-00605-g003.jpg
figlink: /pmc/articles/PMC12108454/figure/F3/
number: F3
caption: OS leads to the overproduction of ROS. Excessive ROS will inhibit the Wnt/β-catenin
  pathway, mitochondrial function and GPX4, and phospholipid peroxidation, leading
  to OB damage; increased ROS can trigger the NF-κB signaling pathway, affect the
  OPG-RANKL-RANK signaling pathway, and promote the activity of OC, which will ultimately
  lead to PMOP. SIRTs and OS exhibit a reciprocal interaction. SIRT1, SIRT3, and SIRT6
  can attenuate OS by activating the expression of antioxidant genes and the ERα-FasL
  axis. The inhibitory effect of SIRTs on OS is weakened when estrogen is deficient,
  affecting bone metabolic homeostasis. The exacerbation of OS affects the activity
  of SIRTs by inhibiting NAD+, impairing mitochondrial function, and oxidatively damaging
  DNA to make the expression of SIRT1, SIRT3, and SIRT6 decrease
papertitle: 'New Perspectives on Postmenopausal Osteoporosis: Mechanisms and Potential
  Therapeutic Strategies of Sirtuins and Oxidative Stress'
reftext: Huiying Zhao, et al. Antioxidants (Basel). 2025 May;14(5).
year: '2025'
doi: 10.3390/antiox14050605
journal_title: Antioxidants
journal_nlm_ta: Antioxidants (Basel)
publisher_name: Multidisciplinary Digital Publishing Institute  (MDPI)
keywords: sirtuins | oxidative stress | postmenopausal osteoporosis | natural activator
  | natural antioxidant
automl_pathway: 0.9396935
figid_alias: PMC12108454__F3
figtype: Figure
redirect_from: /figures/PMC12108454__F3
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC12108454__antioxidants-14-00605-g003.html
  '@type': Dataset
  description: OS leads to the overproduction of ROS. Excessive ROS will inhibit the
    Wnt/β-catenin pathway, mitochondrial function and GPX4, and phospholipid peroxidation,
    leading to OB damage; increased ROS can trigger the NF-κB signaling pathway, affect
    the OPG-RANKL-RANK signaling pathway, and promote the activity of OC, which will
    ultimately lead to PMOP. SIRTs and OS exhibit a reciprocal interaction. SIRT1,
    SIRT3, and SIRT6 can attenuate OS by activating the expression of antioxidant
    genes and the ERα-FasL axis. The inhibitory effect of SIRTs on OS is weakened
    when estrogen is deficient, affecting bone metabolic homeostasis. The exacerbation
    of OS affects the activity of SIRTs by inhibiting NAD+, impairing mitochondrial
    function, and oxidatively damaging DNA to make the expression of SIRT1, SIRT3,
    and SIRT6 decrease
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - SIRT1
  - SIRT3
  - FOXO1
  - FOXO3
  - FOXO4
  - FOXO6
  - SOD2
  - SOD2-OT1
  - PPARGC1A
  - TNFRSF11A
  - IL1A
  - IL1B
  - IL6
  - TNF
  - SIRT6
  - NFKB1
  - ATP8A2
  - WNT1
  - WNT2
  - WNT2B
  - WNT3
  - WNT3A
  - WNT4
  - WNT6
  - WNT7A
  - WNT7B
  - WNT8A
  - WNT8B
  - WNT9A
  - WNT9B
  - WNT10A
  - WNT10B
  - WNT11
  - WNT16
  - WNT5A
  - WNT5B
  - ALPP
  - ATHS
  - SLPI
  - CCL27
  - ATRNL1
  - PDLIM3
  - NAT10
  - ASRGL1
  - COL6A1
  - COL6A2
  - COL6A3
  - COL6A5
  - COL6A6
  - COL7A1
  - COL8A1
  - COL8A2
  - COL9A1
  - COL9A2
  - COL9A3
  - COL10A1
  - COL11A1
  - COL11A2
  - COL12A1
  - COL13A1
  - COL14A1
  - COL15A1
  - COL16A1
  - COL17A1
  - COL18A1
  - COL19A1
  - COL20A1
  - COL21A1
  - COL22A1
  - COL23A1
  - COL24A1
  - COL25A1
  - COL26A1
  - COL27A1
  - COL28A1
  - COL1A1
  - COL1A2
  - COL4A1
  - COL4A2
  - COL4A3
  - COL4A4
  - COL4A5
  - COL4A6
  - COL5A1
  - COL5A2
  - COL5A3
  - TNFSF11
  - BTF3P11
  - TNFRSF11B
  - GPX4
  - ILK
  - RUNX2
  - MID1
  - SP7
  - sirt1
  - sirt3
  - sod2
  - ppargc1a
  - tnfrsf1b
  - il6
  - tnfb
  - sirt6
  - xod
  - alpl
  - pdlim3b
  - ilk
  - sp7
  - NAD
  - TNF-a
  - NOX
  - ROS
  - OPG
  - Lipid
  - 4-HNE
---
